{"avg":{"avg_bot_access":91.6,"avg_rendering":93,"avg_structure":35.3,"avg_schema":9.4,"avg_tech_stack":63.4,"avg_overall":56.8},"domain":{"domain":"ligand.com","crawled_at":"2026-03-20T13:45:52.349005Z","gptbot_allowed":true,"claudebot_allowed":true,"ccbot_allowed":true,"google_extended_allowed":true,"googlebot_allowed":true,"raw_text_length":6013,"rendered_text_length":6013,"ghost_ratio":0,"rendering_type":"SSR","word_count":417,"li_count":59,"tr_count":0,"th_count":0,"structure_score":14.149999618530273,"has_org_schema":true,"has_product_schema":false,"schema_count":1,"tech_stack":"wordpress","server_header":"cloudflare","cdn":"cloudflare","http_status":200,"load_time_ms":1084,"total_html_bytes":169161,"useful_text_bytes":6013,"token_bloat_ratio":28.100000381469727,"images_total":6,"images_with_alt":3,"multimodal_pct":50,"tdm_reservation":false,"has_noai_tag":false,"script_bytes":13978,"has_breadcrumb_schema":true,"has_faq_schema":false,"has_article_schema":false,"has_website_schema":true,"page_title":"Ligand Pharmaceuticals - Biopharma's Technology and Capital Partner","meta_description":"A genetic medicines company developing first-in-class, non-viral, targeted nucleic acid therapeutics utilizing a proprietary gene monoclonal antibody (GMAB) platform technology.","logo_url":"https://ligand.com/wp-content/uploads/favicon96x96.png","crawl_blocked":false,"ai_readiness_score":84,"sub_bot_access":100,"sub_rendering":100,"sub_structure":69,"sub_schema":42,"sub_tech_stack":85,"extractability_score":60,"crawl_cost_score":40,"crawl_cost_label":"Medium","blocklist_risk":0,"blocklist_risk_label":"None","acri_score":56,"acri_extractability":70,"acri_semantic_structure":68,"acri_content_integrity":31,"acri_retrieval_robustness":56,"acri_grade":"C","h1_text":"Biopharma's Technology and Capital Partner","h2_texts":"Technology and financing solutions to advance tomorrow’s medicines | A specialist in healthcare investing | Diversified Portfolio | By the Numbers | Latest News","tranco_rank":506296,"title_length":67,"meta_desc_length":177,"has_canonical":true,"canonical_url":"https://www.ligand.com/","canonical_mismatch":false,"has_meta_viewport":true,"h1_count":1,"h2_count":5,"h2_before_h1":false,"has_hreflang":false,"has_noindex":false,"has_lang_attr":true,"lang_attr":"en-US","og_title":"Ligand Pharmaceuticals - Biopharma's Technology and Capital Partner","og_description":"A genetic medicines company developing first-in-class, non-viral, targeted nucleic acid therapeutics utilizing a proprietary gene monoclonal antibody (GMAB) platform technology.","og_image":"https://www.ligand.com/wp-content/uploads/inset23-.jpg","twitter_card":"summary_large_image","ttfb_ms":1084,"dom_node_count":543,"html_payload_kb":165.2,"has_hsts":false,"has_csp":false,"cf_cache_status":"DYNAMIC","sitemap_declared":true,"sitemap_url":"https://www.ligand.com/sitemap_index.xml","internal_links":66,"external_links":2,"tracker_scripts":0,"tracker_token_pct":0,"global_score":66,"seo_pillar":71,"geo_pillar":65,"perf_pillar":56,"arch_pillar":75,"data_tier":1,"ai_trust_score":0,"ai_trust_rank":0,"ai_trust_percentile":0,"inbound_ai_links":0,"outbound_ai_links":0,"llm_analyzed":true,"llm_analyzed_at":"2026-03-24T02:32:53.533135Z","llm_model":"mlx-community/gemma-3-4b-it-qat-4bit","ai_unified_analysis":{"core_offering":"Ligand Pharmaceuticals provides technology and financing solutions for advancing medicines.","target_audience":"Biopharma investors, healthcare investors","pricing_model":"SEMANTIC VOID","integration_partners":[],"compliance_standards":[],"competitive_moat":"Proprietary GMAB platform technology and specialized healthcare investing expertise.","content_depth_score":3}},"percentile":98,"similar_domains":[{"domain":"stpancras-highspeed.com","acri_score":66,"ai_readiness_score":82,"tech_stack":"wordpress","category":"infrastructure","token_bloat_ratio":18.399999618530273,"schema_count":1,"distance":16.410000228881835,"page_title":"London St. Pancras Highspeed - The Journey Ahead","h1_text":"THE JOURNEY AHEAD"},{"domain":"themesartist.com","acri_score":66,"ai_readiness_score":83,"tech_stack":"wordpress","category":"infrastructure","token_bloat_ratio":16.100000381469727,"schema_count":1,"distance":17.1,"page_title":"Best Free and Premium WordPress Themes - Themes Artist","h1_text":"Beautifully Handcrafted Free and Premium WordPress Themes just for you"},{"domain":"wavecell.com","acri_score":66,"ai_readiness_score":78,"tech_stack":"wordpress","category":"healthcare","token_bloat_ratio":6,"schema_count":1,"distance":18.5,"page_title":"8x8 CPaaS - Communications Platform as a Service","h1_text":"8x8 Wins Best CPaaS Platform at the CX Awards 2025"},{"domain":"tarom.ro","acri_score":66,"ai_readiness_score":78,"tech_stack":"wordpress","category":"social","token_bloat_ratio":9,"schema_count":1,"distance":18.5,"page_title":"TAROM","h1_text":"ZBURĂM PENTRU ROMÂNIA!"},{"domain":"narixasoft.es","acri_score":66,"ai_readiness_score":81,"tech_stack":"wordpress","category":"infrastructure","token_bloat_ratio":9.100000381469727,"schema_count":1,"distance":18.5,"page_title":"▷ Desarrollo de Apps y Páginas Web Profesional ✔️ NarixaSoft.es","h1_text":""}]}